-
2
-
-
84899488124
-
Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: A multicenter retrospective study (2004-2012)
-
Dees DD, Fritz KJ, Maclaren NE, et al. Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: a multicenter retrospective study (2004-2012). Vet Ophthalmol 2014;17:195-200.
-
(2014)
Vet Ophthalmol
, vol.17
, pp. 195-200
-
-
Dees, D.D.1
Fritz, K.J.2
Maclaren, N.E.3
-
3
-
-
0038134974
-
Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: Effect on the quality of life of glaucoma patients with drug-related side effects
-
Nesher R, Ticho U. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects. Isr Med Assoc J 2003;5:260-263.
-
(2003)
Isr Med Assoc J
, vol.5
, pp. 260-263
-
-
Nesher, R.1
Ticho, U.2
-
4
-
-
42149182915
-
The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents
-
Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des 2008;14:649-654.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 649-654
-
-
Mincione, F.1
Scozzafava, A.2
Supuran, C.T.3
-
5
-
-
0035292268
-
Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs
-
Gelatt KN, MacKay EO. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. Vet Ophthalmol 2001;4:61-67.
-
(2001)
Vet Ophthalmol
, vol.4
, pp. 61-67
-
-
Gelatt, K.N.1
MacKay, E.O.2
-
6
-
-
0034981371
-
Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs
-
Cawrse MA, Ward DA, Hendrix DV. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res 2001;62:859-863.
-
(2001)
Am J Vet Res
, vol.62
, pp. 859-863
-
-
Cawrse, M.A.1
Ward, D.A.2
Hendrix, D.V.3
-
7
-
-
0042205440
-
Topical dorzolamide and metabolic acidosis in a neonate
-
Morris S, Geh V, Nischal KK, et al. Topical dorzolamide and metabolic acidosis in a neonate. Br J Ophthalmol 2003;87:1052-1053.
-
(2003)
Br J Ophthalmol
, vol.87
, pp. 1052-1053
-
-
Morris, S.1
Geh, V.2
Nischal, K.K.3
-
8
-
-
0035659025
-
Contact dermatitis to topical drugs for glaucoma
-
Holdiness MR. Contact dermatitis to topical drugs for glaucoma. Am J Contact Dermat 2001;12:217-219.
-
(2001)
Am J Contact Dermat
, vol.12
, pp. 217-219
-
-
Holdiness, M.R.1
-
9
-
-
0032169810
-
Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary openangle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group
-
Silver LH. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary openangle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Am J Ophthalmol 1998;126:400-408.
-
(1998)
Am J Ophthalmol
, vol.126
, pp. 400-408
-
-
Silver, L.H.1
-
10
-
-
0029121112
-
A topical carbonic anhydrase inhibitor for glaucoma
-
A topical carbonic anhydrase inhibitor for glaucoma. Med Lett Drugs Ther 1995;37:76-77.
-
(1995)
Med Lett Drugs Ther
, vol.37
, pp. 76-77
-
-
-
11
-
-
0033825972
-
Marginal keratitis: An uncommon form of topical dorzolamide allergy
-
Taguri AH, Khan MA, Sanders R. Marginal keratitis: an uncommon form of topical dorzolamide allergy. Am J Ophthalmol 2000;130:120-122.
-
(2000)
Am J Ophthalmol
, vol.130
, pp. 120-122
-
-
Taguri, A.H.1
Khan, M.A.2
Sanders, R.3
-
12
-
-
33846554716
-
Drug-induced ectropion: What is best practice?
-
Hegde V, Robinson R, Dean F, et al. Drug-induced ectropion: what is best practice? Ophthalmology 2007;114:362-366.
-
(2007)
Ophthalmology
, vol.114
, pp. 362-366
-
-
Hegde, V.1
Robinson, R.2
Dean, F.3
-
13
-
-
0033119461
-
Irreversible corneal decompensation in patients treated with topical dorzolamide
-
Konowal A, Morrison JC, Brown SV, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol 1999;127:403-406.
-
(1999)
Am J Ophthalmol
, vol.127
, pp. 403-406
-
-
Konowal, A.1
Morrison, J.C.2
Brown, S.V.3
-
14
-
-
38549144643
-
Erythema multiforme after use of topical dorzolamide
-
Munshi V, Ahluwalia H. Erythema multiforme after use of topical dorzolamide. J Ocul Pharmacol Ther 2008;24:91-93.
-
(2008)
J Ocul Pharmacol Ther
, vol.24
, pp. 91-93
-
-
Munshi, V.1
Ahluwalia, H.2
-
15
-
-
0035043766
-
Dorzolamide-induced immune thrombocytopenia: A case report and literature review
-
Martin XD, Danese M. Dorzolamide-induced immune thrombocytopenia: a case report and literature review. J Glaucoma 2001;10:133-135.
-
(2001)
J Glaucoma
, vol.10
, pp. 133-135
-
-
Martin, X.D.1
Danese, M.2
-
16
-
-
78049434564
-
Skin eruption and thrombocytopaenia in a woman with glaucoma: A case report
-
Santos VM, Castro RA, Lima CC, et al. Skin eruption and thrombocytopaenia in a woman with glaucoma: a case report. West Indian Med J 2010;59:102-105.
-
(2010)
West Indian Med J
, vol.59
, pp. 102-105
-
-
Santos, V.M.1
Castro, R.A.2
Lima, C.C.3
-
17
-
-
2342548698
-
Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops
-
Mullins RJ, Lones R, Dutta B. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops. Australas J Dermatol 2004;45:151-152.
-
(2004)
Australas J Dermatol
, vol.45
, pp. 151-152
-
-
Mullins, R.J.1
Lones, R.2
Dutta, B.3
-
18
-
-
39049151289
-
Systemic contact dermatitis to dorzolamide eye drops
-
Kluger N, Guillot B, Raison-Peyron N. Systemic contact dermatitis to dorzolamide eye drops. Contact Dermat 2008;58:167-168.
-
(2008)
Contact Dermat
, vol.58
, pp. 167-168
-
-
Kluger, N.1
Guillot, B.2
Raison-Peyron, N.3
-
19
-
-
0346732913
-
Thygeson's superficial punctate keratitis: Ten years' experience
-
Nagra PK, Rapuano CJ, Cohen EJ, et al. Thygeson's superficial punctate keratitis: ten years' experience. Ophthalmology 2004;111:34-37.
-
(2004)
Ophthalmology
, vol.111
, pp. 34-37
-
-
Nagra, P.K.1
Rapuano, C.J.2
Cohen, E.J.3
-
20
-
-
0032901259
-
Classification of herpes simplex virus keratitis
-
Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea 1999;18:144-154.
-
(1999)
Cornea
, vol.18
, pp. 144-154
-
-
Holland, E.J.1
Schwartz, G.S.2
-
21
-
-
84886840259
-
Preservative toxicity in glaucoma medication: Clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
-
Rosin LM, Bell NP. Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clin Ophthalmol 2013;7:2131-2135.
-
(2013)
Clin Ophthalmol
, vol.7
, pp. 2131-2135
-
-
Rosin, L.M.1
Bell, N.P.2
-
22
-
-
67650899102
-
Outbreak of ocular disease associated with naturally-acquired canine herpesvirus-1 infection in a closed domestic dog colony
-
Ledbetter EC, Kim SG, Dubovi EJ. Outbreak of ocular disease associated with naturally-acquired canine herpesvirus-1 infection in a closed domestic dog colony. Vet Ophthalmol 2009;12:242-247.
-
(2009)
Vet Ophthalmol
, vol.12
, pp. 242-247
-
-
Ledbetter, E.C.1
Kim, S.G.2
Dubovi, E.J.3
-
23
-
-
14944366026
-
Efficacy of topical nerve growth factor treatment in dogs affected by dry eye
-
Coassin M, Lambiase A, Costa N, et al. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefes Arch Clin Exp Ophthalmol 2005;243:151-155.
-
(2005)
Graefes Arch Clin Exp Ophthalmol
, vol.243
, pp. 151-155
-
-
Coassin, M.1
Lambiase, A.2
Costa, N.3
-
25
-
-
78549255878
-
Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT) in patients with elevated intraocular pressure in a randomized clinical trial
-
Shedden A, Adamsons IA, Getson AJ, et al. Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT) in patients with elevated intraocular pressure in a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 2010;248:1757-1764.
-
(2010)
Graefes Arch Clin Exp Ophthalmol
, vol.248
, pp. 1757-1764
-
-
Shedden, A.1
Adamsons, I.A.2
Getson, A.J.3
-
26
-
-
79955016801
-
Ocular surface disease in patients with ocular hypertension and glaucoma
-
Stewart WC, Stewart JA, Nelson LA. Ocular surface disease in patients with ocular hypertension and glaucoma. Curr Eye Res 2011;36:391-398.
-
(2011)
Curr Eye Res
, vol.36
, pp. 391-398
-
-
Stewart, W.C.1
Stewart, J.A.2
Nelson, L.A.3
-
27
-
-
0344305392
-
Ocular factors relevant to antiglaucomatous eyedrop-related keratoepitheliopathy
-
Inoue K, Okugawa K, Kato S, et al. Ocular factors relevant to antiglaucomatous eyedrop-related keratoepitheliopathy. J Glaucoma 2003;12:480-485.
-
(2003)
J Glaucoma
, vol.12
, pp. 480-485
-
-
Inoue, K.1
Okugawa, K.2
Kato, S.3
-
28
-
-
84856111207
-
A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatographytandem mass spectrometry
-
Kahook MY, Fechtner RD, Katz LJ, et al. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatographytandem mass spectrometry. Curr Eye Res 2012;37:101-108.
-
(2012)
Curr Eye Res
, vol.37
, pp. 101-108
-
-
Kahook, M.Y.1
Fechtner, R.D.2
Katz, L.J.3
-
29
-
-
0027207867
-
Double-blind controlled study of methazolamide in the treatment of essential tremor
-
Busenbark K, Pahwa R, Hubble J, et al. Double-blind controlled study of methazolamide in the treatment of essential tremor. Neurology 1993;43:1045-1047.
-
(1993)
Neurology
, vol.43
, pp. 1045-1047
-
-
Busenbark, K.1
Pahwa, R.2
Hubble, J.3
-
30
-
-
0034056033
-
Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: Results from two multicenter comfort studies. Brinzolamide Comfort Study Group
-
Silver LH. Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group. Surv Ophthalmol 2000;44(Suppl 2):S141-S145.
-
(2000)
Surv Ophthalmol
, vol.44
, pp. S141-S145
-
-
Silver, L.H.1
-
31
-
-
80054058311
-
From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: A 6-month, multicenter, open-label tolerability switch study
-
Rossi GC, Pasinetti GM, Sandolo F, et al. From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch study. Expert Opin Pharmacother 2011;12:2425-2431.
-
(2011)
Expert Opin Pharmacother
, vol.12
, pp. 2425-2431
-
-
Rossi, G.C.1
Pasinetti, G.M.2
Sandolo, F.3
-
32
-
-
0036895588
-
The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern."
-
Fung MA. The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern." J Am Acad Dermatol 2002;47:898-907.
-
(2002)
J Am Acad Dermatol
, vol.47
, pp. 898-907
-
-
Fung, M.A.1
-
33
-
-
84876584468
-
Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients
-
Rossi GC, Pasinetti GM, Scudeller L, et al. Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients. Eur J Ophthalmol 2013;23:296-302.
-
(2013)
Eur J Ophthalmol
, vol.23
, pp. 296-302
-
-
Rossi, G.C.1
Pasinetti, G.M.2
Scudeller, L.3
-
34
-
-
79953183017
-
Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue
-
Servat JJ, Bernardino CR. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging 2011;28:267-282.
-
(2011)
Drugs Aging
, vol.28
, pp. 267-282
-
-
Servat, J.J.1
Bernardino, C.R.2
|